Minagawa, Hikaru
Hashii, Yoshiko
Nakajima, Hiroko
Fujiki, Fumihiro
Morimoto, Soyoko
Nakata, Jun
Shirakawa, Toshiro
Katayama, Takane
Tsuboi, Akihiro
Ozono, Keiichi
Article History
Received: 15 August 2022
Accepted: 13 January 2023
First Online: 20 February 2023
Declarations
:
: The protocol of the present study was approved by Osaka University Animal Experiment Committee and by Osaka University’s Safety Management Regulations on Recombinant DNA Experiment. All methods were carried out in accordance with relevant guidelines and regulations and the study was carried out in compliance with the ARRIVE guidelines.
: Not applicable.
: YH has received grants from AMED SPRINT Seeds B 21lm0203091s0103 and JSPS-KAKENHI JP 21 K07841. TK has received grant JSPS-KAKENHI JP 21 K07841 from during the conduct of the study. TK and TS has received stock options from Immunorock Co., Ltd. TS has received grant from AMED SPRINT Seeds B 21lm0203091h0003. All other authors declared no competing interests.